Male circumcision and HIV infection risk
- John N. KriegerAffiliated withDepartment of Urology, School of Medicine, University of Washington Email author
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Male circumcision is being promoted to reduce human immunodeficiency virus type 1 (HIV) infection rates. This review evaluates the scientific evidence suggesting that male circumcision reduces HIV infection risk in high-risk heterosexual populations.
We followed the updated International Consultation on Urological Diseases evidence-based medicine recommendations to critically review the scientific evidence on male circumcision and HIV infection risk.
Level 1 evidence supports the concept that male circumcision substantially reduces the risk of HIV infection. Three major lines of evidence support this conclusion: biological data suggesting that this concept is plausible, data from observational studies supported by high-quality meta-analyses, and three randomized clinical trials supported by high-quality meta-analyses.
The evidence from these biological studies, observational studies, randomized controlled clinical trials, meta-analyses, and cost-effectiveness studies is conclusive. The challenges to implementation of male circumcision as a public health measure in high-risk populations must now be faced.
KeywordsMale circumcision HIV infection Risk Complications
- Male circumcision and HIV infection risk
World Journal of Urology
Volume 30, Issue 1 , pp 3-13
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Male circumcision
- HIV infection
- Industry Sectors
- John N. Krieger (1)
- Author Affiliations
- 1. Department of Urology, School of Medicine, University of Washington, Seattle, WA, 98195, USA